Niagen Bioscience, Inc. company logo
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. (CDXC)

Summary

Revenue
CDXC current annual revenue is $99.60M, up +19.18% year-over-year
Next Earnings
As of today, the next earnings release for CDXC has not been scheduled

Profile

Company profile for Niagen Bioscience, Inc. (CDXC)
MetricValue
Full NameNiagen Bioscience, Inc.
TickerNASDAQ: CDXC
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitechromadex.com
Employees104

Key Metrics

Niagen Bioscience, Inc. Key Details
MetricValueDate
Price-
Price, 1D Change-
-
-
-
-N/A
$99.60M
Revenue, 1Y Change+19.18%
$0.11
EPS, 1Y Change+257.14%

Chart

SUGGESTED SERIES
Niagen Bioscience, Inc. chart

Events

Niagen Bioscience, Inc. Events
MetricValueDate
Next EarningsN/A
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split1:3
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

CDXC Estimates
MetricValueDate
$0.11
EPS Estimate$0.12N/A
EPS Est. Change+6.09%N/A
$99.60M
Revenue Estimate$118.50MN/A
Revenue Est. Change+18.98%N/A
Current Price-
Price Target$8.10-
Price Tgt. Change--

🔒 Log In To Unlock Full Data

EPS

CDXC EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$0.09-$0.07+22.22%
$0.04$0.11+205.56%
$0.12N/A+6.09%
$0.20N/A+78.82%
CDXC EPS reported versus estimate values chart

Revenue

CDXC revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$83.38M$83.57M+0.23%
$96.94M$99.60M+2.75%
$118.50MN/A+18.98%
$143.83MN/A+44.41%
CDXC revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

CDXC Performance
MetricValueDate
Price, 1Y-
Price, 3Y-
-
-
+19.18%
+47.66%
+257.14%
+127.50%

🔒 Log In To Unlock Full Data

Technicals

CDXC Technical Indicators
MetricValueDate
Current Price-
-N/A
-N/A
-N/A
-N/A
-N/A
-N/A
-N/A
-N/A
-N/A

Dividends

CDXC Dividends
MetricValueDate
-N/A
UpcomingN/AN/A
-
-
-
-

🔒 Log In To Unlock Full Data

Income & Profitability

CDXC Income & Profitability
MetricValueDate
$99.60M
$0.11
$61.59M
61.84%
$7.73M
7.76%
$8.55M
8.58%
$9.21M

🔒 Log In To Unlock Full Data

Financial Health

CDXC Financial Health
MetricValueDate
0.00
3.57
3.06
-
7
-

Valuations

CDXC Valuations
MetricValueDate
-
-
-
-
-N/A

Balance Sheet

CDXC Balance Sheet
MetricValueDate
$46.09M
$44.51M
$68.28M
$64.10M
$22.18M
$17.95M
$2.65M
$994.00K
$8.53M

Expenses

CDXC Expenses
MetricValueDate
$91.87M
$53.86M
$38.01M
$47.84M
$1.48M
-
$305.00K

Cash Flow

CDXC Cash Flow
MetricValueDate
$12.11M
-$143.00K
$5.37M
$163.00K
$11.95M

Recent analyst updates

CDXC Recent analyst updates
MetricValueDate
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
Ladenburg Thalmann
Roth MKM
HC Wainwright & Co.
HC Wainwright & Co.
HC Wainwright & Co.
Roth MKM

Analyst sentiment

Sentiment over the past month
CDXC analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
CDXC institutional ownership distribution chart

Screeners with CDXC

FAQ

What is the ticker symbol for Niagen Bioscience, Inc.?
The ticker symbol for Niagen Bioscience, Inc. is NASDAQ:CDXC
Does Niagen Bioscience, Inc. pay dividends?
No, Niagen Bioscience, Inc. does not pay dividends
What sector is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. is in the Healthcare sector
What industry is Niagen Bioscience, Inc. in?
Niagen Bioscience, Inc. is in the Biotechnology industry
What country is Niagen Bioscience, Inc. based in?
Niagen Bioscience, Inc. is headquartered in United States
When did Niagen Bioscience, Inc. go public?
Niagen Bioscience, Inc. initial public offering (IPO) was on June 25, 2008
Is Niagen Bioscience, Inc. in the S&P 500?
No, Niagen Bioscience, Inc. is not included in the S&P 500 index
Is Niagen Bioscience, Inc. in the NASDAQ 100?
No, Niagen Bioscience, Inc. is not included in the NASDAQ 100 index
Is Niagen Bioscience, Inc. in the Dow Jones?
No, Niagen Bioscience, Inc. is not included in the Dow Jones index
When was Niagen Bioscience, Inc. last earnings report?
Niagen Bioscience, Inc.'s most recent earnings report was on May 8, 2025
When does Niagen Bioscience, Inc. report earnings?
The date for Niagen Bioscience, Inc.'s next earnings report has not been announced yet

Data Sources & References

  1. CDXC Official Website www.chromadex.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1386570/000162828025023127/0001628280-25-023127-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1386570/000162828025009774/0001628280-25-009774-index.htm
  4. CDXC Profile on Yahoo Finance finance.yahoo.com/quote/CDXC
  5. CDXC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cdxc